These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 23000499)

  • 21. OVERDOSED ON OPIOIDS: A deadly opioid epidemic sweeping the country has lawmakers working hard to find solutions.
    Hoback J
    State Legis; 2016 Apr; 42(4):9-13. PubMed ID: 27071212
    [No Abstract]   [Full Text] [Related]  

  • 22. Prehospital Naloxone Administration as a Public Health Surveillance Tool: A Retrospective Validation Study.
    Lindstrom HA; Clemency BM; Snyder R; Consiglio JD; May PR; Moscati RM
    Prehosp Disaster Med; 2015 Aug; 30(4):385-9. PubMed ID: 26061280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is a Prehospital Treat and Release Protocol for Opioid Overdose Safe?
    Kolinsky D; Keim SM; Cohn BG; Schwarz ES; Yealy DM
    J Emerg Med; 2017 Jan; 52(1):52-58. PubMed ID: 27769615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can nebulized naloxone be used safely and effectively by emergency medical services for suspected opioid overdose?
    Weber JM; Tataris KL; Hoffman JD; Aks SE; Mycyk MB
    Prehosp Emerg Care; 2012; 16(2):289-92. PubMed ID: 22191727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. OPIOID CRISIS. Prehospital naloxone administration for opioid-related emergencies.
    Drennan IR; Orkin AM
    JEMS; 2016 Mar; 41(3):36-9. PubMed ID: 27120853
    [No Abstract]   [Full Text] [Related]  

  • 26. Emergency department naloxone distribution: a Rhode Island department of health, recovery community, and emergency department partnership to reduce opioid overdose deaths.
    Samuels E
    R I Med J (2013); 2014 Oct; 97(10):38-9. PubMed ID: 25271659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opium use: an emerging risk factor for cancer?
    Kamangar F; Shakeri R; Malekzadeh R; Islami F
    Lancet Oncol; 2014 Feb; 15(2):e69-77. PubMed ID: 24480557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are Opioid Deaths Affected by Macroeconomic Conditions?
    Natl Bur Econ Res Bull Aging Health; 2017; (3):1-2. PubMed ID: 28820565
    [No Abstract]   [Full Text] [Related]  

  • 29. Police Officers Can Safely and Effectively Administer Intranasal Naloxone.
    Fisher R; O'Donnell D; Ray B; Rusyniak D
    Prehosp Emerg Care; 2016; 20(6):675-680. PubMed ID: 27218446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of naloxone for reversal of life-threatening opioid toxicity in cancer-related pain.
    Howlett C; Gonzalez R; Yerram P; Faley B
    J Oncol Pharm Pract; 2016 Feb; 22(1):114-20. PubMed ID: 25227231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Opioid Overdose Outbreak - West Virginia, August 2016.
    Massey J; Kilkenny M; Batdorf S; Sanders SK; Ellison D; Halpin J; Gladden RM; Bixler D; Haddy L; Gupta R
    MMWR Morb Mortal Wkly Rep; 2017 Sep; 66(37):975-980. PubMed ID: 28934186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary care management of opioid use disorders: Abstinence, methadone, or buprenorphine-naloxone?
    Srivastava A; Kahan M; Nader M
    Can Fam Physician; 2017 Mar; 63(3):200-205. PubMed ID: 28292795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emergency medical services naloxone access: a national systematic legal review.
    Davis CS; Southwell JK; Niehaus VR; Walley AY; Dailey MW
    Acad Emerg Med; 2014 Oct; 21(10):1173-7. PubMed ID: 25308142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lessons learned from the expansion of naloxone access in Massachusetts and North Carolina.
    Davis CS; Walley AY; Bridger CM
    J Law Med Ethics; 2015; 43 Suppl 1():19-22. PubMed ID: 25846157
    [No Abstract]   [Full Text] [Related]  

  • 35. Sleep-disordered breathing in patients with opioid use disorders in long-term maintenance on buprenorphine-naloxone: A case series.
    DeVido J; Connery H; Hill KP
    J Opioid Manag; 2015; 11(4):363-6. PubMed ID: 26312963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of naloxone in opiate poisoning.
    Evans LE
    Br Med J; 1973 Jun; 2(5868):717. PubMed ID: 4733262
    [No Abstract]   [Full Text] [Related]  

  • 37. Characteristics and outcomes of patients discharged from the Opioid Renewal Clinic at the Philadelphia VA Medical Center.
    Becker WC; Meghani SH; Barth KS; Wiedemer N; Gallagher RM
    Am J Addict; 2009; 18(2):135-9. PubMed ID: 19283565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of the Opium Neurosis: By Stephen Lett, M.D., Ont., Canada.
    JAMA; 2017 Oct; 318(16):1617. PubMed ID: 29067412
    [No Abstract]   [Full Text] [Related]  

  • 39. Counseling plus buprenorphine-naloxone for opioid dependence.
    Gorelick DA
    N Engl J Med; 2006 Oct; 355(16):1736; author reply 1736-7. PubMed ID: 17050900
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment completion on an inpatient detoxification unit: impact of a change to sublingual buprenorphine-naloxone.
    Soeffing JM; Rastegar DA
    J Subst Abuse Treat; 2007 Dec; 33(4):401-4. PubMed ID: 17400414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.